Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer
- 1 October 2004
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 46 (1) , 77-85
- https://doi.org/10.1016/j.lungcan.2004.03.018
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Relevance of p53, bcl-2 and Rb expression on resistance to cisplatin-based chemotherapy in advanced non-small cell lung cancerLung Cancer, 2003
- Aberrant p53 Expression Correlates With Expression of Vascular Endothelial Growth Factor mRNA and Interleukin-8 mRNA and Neoangiogenesis in Non-Small-Cell Lung CancerJournal of Clinical Oncology, 2002
- A biological staging model for operable non-small cell lung cancerThorax, 2001
- Molecular biologic substaging of stage I lung cancer according to gender and histologyThe Annals of Thoracic Surgery, 2000
- Vascular endothelial growth factor and lymph node metastasis in primary lung cancerBritish Journal of Cancer, 1997
- Revisions in the International System for Staging Lung CancerChest, 1997
- Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expressionBritish Journal of Cancer, 1997
- p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP resultsBritish Journal of Cancer, 1994
- Multifactorial analysis of p53 alteration in human cancer: A reviewInternational Journal of Cancer, 1994
- Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitroInternational Journal of Cancer, 1990